Brand Name | Status | Last Update |
---|---|---|
asce plus derma signal kit srlv | unapproved drug other | 2021-11-23 |
clinimix | New Drug Application | 2021-04-13 |
clinimix e | New Drug Application | 2021-04-13 |
clinisol | ANDA | 2018-06-01 |
exoscrt derma signal kit srlv | unapproved drug other | 2021-11-23 |
exoscrt derma signal srlv vial 1. lyophilized | unapproved drug other | 2024-12-09 |
exoscrt derma signal srlv vial 2. diluent | unapproved drug other | 2024-12-09 |
ilevro | New Drug Application | 2025-07-16 |
kabiven | New Drug Application | 2023-08-02 |
lebody fit | unapproved drug other | 2017-11-23 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Heart failure | D006333 | EFO_0003144 | I50 | 2 | 2 | — | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | — | — | — | — | 1 |
Renal insufficiency | D051437 | — | N19 | 1 | — | — | — | — | 1 |
Drug common name | Isoleucine |
INN | isoleucine |
Description | 2-amino-3-methylpentanoic acid is a branched chain amino acid that consists of 3-methylpentanoic acid bearing an amino substituent at position 2. It is an alpha-amino acid and a branched-chain amino acid. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC[C@H](C)[C@H](N)C(=O)O |
PDB | — |
CAS-ID | 73-32-5 |
RxCUI | — |
ChEMBL ID | CHEMBL1233584 |
ChEBI ID | 17191 |
PubChem CID | 791 |
DrugBank | DB00167 |
UNII ID | 04Y7590D77 (ChemIDplus, GSRS) |